Tramadol testing in professional cycling
As of March 1st 2019, the Union Cycliste Internationale (UCI) banned in-competition use of tramadol across all cycling disciplines. Tramadol is a commonly available pain killer (opioid) that induces dependence, drowsiness and concentration deficits. The use of such a drug greatly increases crash risks and health issues. Controls are now common in professional cycling, especially in the pinnacle of competitions: WorldTour stage races where riders are sampled upon race completion, thanks to the use of HemaXis.
The Research and Expertise in anti-Doping sciences (REDs) from the University of Lausanne was mandated by the UCI to develop and validate an analytical method to monitor Tramadol misuse and to coordinate the field operational implementation in collaboration with the Cycling Anti-Doping Foundation (CADF).
HemaXis DB10 was selected as the ideal tool to perform reliable, fast and minimally invasive blood sampling at the finish line. Additionally, the generation of Dried Blood Spots (DBS) allows more compact storage, easier transport and more stable samples. Overall, the use of HemaXis DB10 is a cheap and convenient in-competition blood sampling solution.
Glimpse of the testing program
The testing program has been continued through the 2019 season and beyond.
Start Using HemaXis DB10
Contact us for more information on how to integrate HemaXis DB10 into your workflow.